Avid Bioservices: Quasar Medical Enhances CDMO Capabilities Through Strategic Acquisition of Nordson Assets
- Quasar Medical enhances its capabilities by acquiring Nordson's contract manufacturing businesses, becoming a fully integrated CDMO.
- The acquisition expands Quasar’s workforce by nearly 200 skilled employees, boosting innovation in the medical device sector.
- Quasar aims to offer end-to-end solutions for interventional devices, emphasizing operational excellence and customer service in MedTech.
Quasar Medical Expands Capabilities with Strategic Acquisition
Quasar Medical demonstrates a significant leap in its operational capabilities by acquiring Nordson Corporation's contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. This acquisition transforms Quasar into a fully integrated Contract Development and Manufacturing Organization (CDMO), allowing the company to provide comprehensive solutions from concept to commercialization for medical device original equipment manufacturers (OEMs) and innovators. The move not only expands Quasar's workforce by nearly 200 skilled employees, including development engineers and technicians, but also enhances its ability to drive innovation in the medical device sector.
CEO Alex Wallstein highlights the strategic advantages of this acquisition, stating that it significantly strengthens Quasar's global reach and solidifies partnerships with customers and suppliers throughout the product lifecycle. The new FDA-registered and ISO 13485-certified facilities are strategically located in key MedTech regions, ensuring that Quasar can improve customer proximity and access. The Galway site is poised to become an innovation hub, focusing on advanced product design, prototyping, and clinical innovation, while the Tecate facility will bolster Quasar's capabilities in high-volume manufacturing. This dual approach positions the company to facilitate smoother transitions for clients moving from development to commercialization.
COO Aviel Bohnik reinforces the importance of this acquisition by noting that it allows Quasar to redefine its role in the industry as a strategic partner, rather than merely a manufacturer. By integrating Nordson Medical's capabilities, Quasar can now offer a seamless, end-to-end solution for complex interventional devices, enhancing its commitment to delivering high-value solutions across key global regions. This evolution not only boosts Quasar's service offerings but also emphasizes its focus on operational excellence and innovative solutions tailored to meet the demanding needs of the MedTech industry.
In light of this acquisition, Quasar Medical is poised to play a vital role in the rapidly evolving landscape of medical device manufacturing. The combination of enhanced workforce capacity and cutting-edge facilities positions the company to meet increasing demands while driving technological advancements in the field.
As Quasar Medical continues to expand its footprint in the CDMO space, the company’s focus on innovation and scalability could set new benchmarks for operational excellence in the medical device sector. This strategic move not only highlights Quasar's ambition but also reflects the growing trend of consolidation within the industry as companies seek to enhance their capabilities and improve customer service.